1. Akimoto M, Ishii H, Nakajima Y, Iwasaki H (1986): Assesment of host immune response in breast cancer patients. Cancer Detect Prev 9:311–317
2. An T, Sood U, Pietruk T, Cummings G (1987): In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Am J Path 128:52–60
3. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB, Sporn MB (1994): Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with Tamoxifen. Cancer Res 54:4614–4617
4. Aronica SM, Katzenellenbogen BS (1993): Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 7:743–752
5. Arteaga CL, Kitten L, Coronado E, Jacobs S, Kuli F, Osborne CK (1989): Blockade of the type-I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423